Alnylam Pharmaceuticals, Inc. (ALNY)

365.33 +9.80 (+2.76%) USD  |  NASDAQ  |  Jan 21, 16:00
361.34 -3.99 (-1.09%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade